Aptinyx Inc.
APTXDelisted Jul 10, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001674365
Aptinyx Inc. was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Jan 5, 2023; 32 institutions reported holding it in 13F filings for Q1 2023, worth $2.44M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Aptinyx Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- −1 vs. Q2 2022
- Shares held
- 31.1M
- −3.11M (−9.1%) vs. Q2 2022
- Total value
- $11.5M
- −$7.61M (−39.9%) vs. Q2 2022
- New holders
- 9
- 2 more added
- Sold out
- 10
- 12 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting APTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 1 | $7.00K |
| Q2 2023 | 3 | $24.0K |
| Q1 2023 | 32 | $2.44M |
| Q4 2022 | 35 | $8.33M |
| Q3 2022 | 40 | $11.5M |
| Q2 2022 | 41 | $19.1M |
| Q1 2022 | 60 | $81.3M |
| Q4 2021 | 49 | $92.4M |
| Q3 2021 | 50 | $79.8M |
| Q2 2021 | 66 | $99.8M |
| Q1 2021 | 70 | $122.1M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Aptinyx Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,891,758 | $3.27M | 0.39% | 00.0% | Unchanged |
| Artal Group S.A. | 6,116,493 | $2.25M | 0.12% | 00.0% | Unchanged |
| Adams Street Partners LLC | 5,395,996 | $2.00M | 0.55% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 1,954,698 | $720.0K | 0.02% | +1,954,698 | New |
| Frazier Life Sciences Management, L.P. | 1,883,244 | $693.0K | 0.05% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,814,948 | $668.0K | 0.00% | −149,110−7.6% | Reduced |
| Millennium Management LLC | 1,203,987 | $443.0K | 0.00% | −312,739−20.6% | Reduced |
| BlackRock Inc. | 685,862 | $253.0K | 0.00% | −339,739−33.1% | Reduced |
| Renaissance Technologies LLC | 541,026 | $199.0K | 0.00% | −27,888−4.9% | Reduced |
| Point72 Asset Management, L.P. | 410,416 | $151.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 378,414 | $139.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 222,200 | $82.0K | 0.00% | −11,200−4.8% | Reduced |
| Meridian Wealth Management, LLC | 192,000 | $71.0K | 0.01% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 184,525 | $68.0K | 0.00% | −42,962−18.9% | Reduced |
| Northern Trust Corp | 150,068 | $56.0K | 0.00% | −58,197−27.9% | Reduced |
| State Street Corp | 138,251 | $51.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 124,041 | $46.0K | 0.00% | −33,600−21.3% | Reduced |
| Acadian Asset Management LLC | 126,777 | $45.0K | 0.00% | +67,392+113.5% | Added |
| Northwestern University | 109,280 | $40.0K | 0.04% | 00.0% | Unchanged |
| Jane Street Group, LLC | 105,771 | $39.0K | 0.00% | +72,006+213.3% | Added |
| Bank of New York Mellon Corp | 80,858 | $30.0K | 0.00% | 00.0% | Unchanged |
| Assenagon Asset Management S.A. | 75,283 | $28.0K | 0.00% | −41,531−35.6% | Reduced |
| Raymond James & Associates | 74,025 | $27.0K | 0.00% | 00.0% | Unchanged |
| HBK Sorce Advisory LLC | 26,000 | $26.0K | 0.00% | +26,000 | New |
| Group One Trading, L.P. | 47,634 | $18.0K | 0.00% | −23,594−33.1% | Reduced |
| Cetera Advisor Networks LLC | 40,000 | $15.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 27,395 | $10.0K | 0.00% | +27,395 | New |
| Virtu Financial LLC | 23,806 | $9.00K | 0.00% | +23,806 | New |
| Blair William & Co | 19,877 | $7.00K | 0.00% | 00.0% | Unchanged |
| Gabelli Funds LLC | 10,901 | $4.00K | 0.00% | 00.0% | Unchanged |
| Calamos Wealth Management LLC | 10,000 | $4.00K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 10,873 | $4.00K | 0.00% | +10,873 | New |
| HRT Financial LP | 13,083 | $4.00K | 0.00% | +13,083 | New |
| Federation des caisses Desjardins du Quebec | 10,000 | $3.68K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 7,928 | $3.00K | 0.00% | −59,913−88.3% | Reduced |
| Wells Fargo & Company | 1,261 | $0 | 0.00% | −15−1.2% | Reduced |
| Navigation Wealth Management, Inc. | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 1,050 | $0 | 0.00% | +1,050 | New |
| Royal Bank of Canada | 432 | $0 | 0.00% | +432 | New |
| Allworth Financial LP | 1,000 | $0 | 0.00% | +1,000 | New |
| New Leaf Venture Partners, L.L.C. | 0 | $0 | 0.00% | −3,290,079−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −538,500−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −263,954−100.0% | Sold out |
| DCF Advisers, LLC | 0 | $0 | 0.00% | −48,529−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −37,152−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −13,200−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −12,342−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −5,772−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |